| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.07 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.07 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.07 |
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.07 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | -0.059 | 0.07 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | -0.066 | 0.07 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.056 | 0.07 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | -0.072 | 0.08 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.067 | 0.08 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.08 |